The Health Cluster Portugal – Health Competitiveness Pole (HCP) has as its main objective the promotion and the exercise of initiatives and activities aimed at the consolidation of a national pole of competitiveness, innovation and technology of international vocation and, of quality and professionalism. Health Cluster Portugal seeks to promote and encourage cooperation between companies, organizations, universities and public entities, with a view to increasing their respective turnover, exports and qualified employment in the economic areas associated with health, as well as overall improvement of health care delivery.
Company
Tecmaia – Science and Technology Park of Maia, Rua Eng.ºFrederico Ulrich, 2650, Moreira da Maia, Portugal
Health Cluster Portugal is currently spearheading a EUR 90 million EU post-COVID Recovery and Resilience Plan (RRP) project in Portugal focused on smart health, secondary use of data, and clinical…
Joaquim Cunha, executive director of Health Cluster Portugal – a private, non-profit organisation dedicated to the consolidation of Portugal’s healthcare industry – discusses the up and coming changes to the…
Joaquim Cunha, Executive Director of Health Cluster Portugal (HCP), emphasizes Portugal’s need to discover niches in which the country can excel and compete globally, while rebranding its image around the…
Diabetes is a rising threat to the Portuguese people, the country’s healthcare system, and its economy. Portugal’s National Diabetes Observatory observed that 1.1 million Portuguese people between the ages of…
Novo Nordisk’s spectacular ascendancy in 2023 has meant that its country managers across the world have had to embrace scrutiny and press coverage like never before. In its centenary…
Luis Abrantes explains how Generis, as one of the leading companies by volume in both the retail and hospital segments of the Portuguese pharma market, serves a huge number of…
Azevedos Group’s João Sotana outlines the firm’s diverse strategic pillars, including manufacturing for Portugal and international markets; its focus on sustainability and innovation; and how it plans to stay ahead…
After achieving the highest sales figures in the affiliate’s history in 2023, general manager of Teva Pharmaceuticals Portugal Marta Gonzalez Casal outlines the restructuring efforts that have taken place in…
While not a major player in clinical trials at the European level, Portugal has untapped potential in this field, leveraging a first pioneering centre in Braga, the country’s strong scientific…
Monica Bettencourt-Dias of the Gulbenkian Institute for Science highlights the IGC’s pioneering role in biological sciences, supporting scientists and innovators who have significantly contributed to the field globally for over…
Alberto Navia-Osorio Pascual enthusiastically describes how Viatris has established itself as the leading pharmaceutical company in Portugal, leveraging the strengths of its integrated portfolios. The company has focused on brand…
Paula Barriga, VP & GM at Novo Nordisk Portugal, discusses the high prevalence of obesity, which affects over two million people in a country where none of the available pharmacological…
The Portuguese Association of Hospital Pharmacists (APFH) is dedicated to the education and training of over 1000 hospital pharmacists; essential members of the multidisciplinary teams needed to tackle serious illnesses…
João Rito introduces Bluebio Alliance, a Portuguese association focusing on bio-based marine resources and their sustainable utilisation. Rito’s work involves extensive collaboration across sectors, including pharmaceuticals, to promote the blue…
Boehringer Ingelheim has a 60-year history in Portugal and, despite challenges in terms of market access and reimbursement delays, remains fully committed to providing innovative healthcare solutions in the country.…
See our Cookie Privacy Policy Here
